Skip to main content

Advertisement

Table 2 Patient’s Characteristics according to pathological Stage and Gleason score

From: Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study

  < pT3a ≥ pT3a p GS < 4 + 3 GS ≥ 4 + 3 p
Patients (%) 223 (64 %) 126 (36 %)   204 (58.5 %) 145 (41.5 %)  
Age, years 63.44 ± 6.28 (65;59/68) 65.97 ± 5.97 (66;62/70) <0.001 63.43 ± 6.16 (64;59/68) 64.69 ± 6.28 (66;61/69) 0.158
TRUS Volume, ml 76 ± 44.05 (60;44/96) 51.53 ± 29.86 (47;33.6/60) <0.001 56.31 ± 31.57 (50;38/62.5) 53.23 ± 29.54 (49.5;35.5/57.9) 0.018
Waist, cm 99.30 ± 8.13 (98.87;96/102.77) 100.34 ± 9.22 (98.87;96/102.77) 0.503 99.21 ± 8.88 (99;94/105) 98.63 ± 10.89 (97;92/103) 0.549
BMI, kg/m2 26.64 ± 3.59 (26.98;24/28.65) 27.07 ± 3.79 (26.4;24/30) 0.149 26.51 ± 3.54 (26.98;24/28.4) 27.10 ± 3.8 (26.52;24/29.2) 0.131
PSA, ng/ml 7.81 ± 4.55 (6.8;4.79/9.43) 14.54 ± 17.84 (8.28;6.23/14.09) <0.001 8.79 ± 8.16 (6.6;4.96/9.42) 13.22 ± 18.22 (8.7;6.15/11.7) <0.001
Trygliceridemia, mg/dl 130.65 ± 63.4 (105;83/163) 136.23 ± 65.86 (122;86/161.5) 0.648 130.92 ± 50.74 (126;94/152) 135.25 ± 60 (126;94/152) 0.552
Glycaemia, mg/dl 100.83 ± 19.68 (98;91/104) 103.87 ± 21.1 (98;92/111) 0.159 100.19 ± 20.85 (95;88/107) 103.84 ± 23.15 (96;88/108) 0.153
HDL, mg/dl 52.14 ± 11.73 (52;45/56) 50.78 ± 12.34 (52;44/55.25) 0.925 52.1 ± 11.14 (52;46/55) 51.03 ± 12.99 (52;43/56.75) 0.213
Hypertension 102/223 (47 %) 74/126 (59 %) 0.037 88/204 (43 %) 91/145 (63 %) 0.001
  1. Kruskal Wallis test for continuous variables, chi square test for categorical variables. GS = Gleason score